1. Home
  2. CSTL vs SNCY Comparison

CSTL vs SNCY Comparison

Compare CSTL & SNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$39.54

Market Cap

661.7M

Sector

Health Care

ML Signal

HOLD

Logo Sun Country Airlines Holdings Inc.

SNCY

Sun Country Airlines Holdings Inc.

HOLD

Current Price

$13.72

Market Cap

652.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSTL
SNCY
Founded
2007
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Air Freight/Delivery Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
661.7M
652.6M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
CSTL
SNCY
Price
$39.54
$13.72
Analyst Decision
Strong Buy
Buy
Analyst Count
6
6
Target Price
$38.67
$19.17
AVG Volume (30 Days)
588.2K
836.8K
Earning Date
11-03-2025
10-29-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
28.51
EPS
N/A
1.05
Revenue
$343,530,000.00
$1,106,213,000.00
Revenue This Year
N/A
$6.16
Revenue Next Year
N/A
$9.63
P/E Ratio
N/A
$13.05
Revenue Growth
10.15
4.27
52 Week Low
$14.59
$8.10
52 Week High
$40.61
$18.59

Technical Indicators

Market Signals
Indicator
CSTL
SNCY
Relative Strength Index (RSI) 80.57 64.90
Support Level $33.03 $11.24
Resistance Level $35.49 $13.90
Average True Range (ATR) 1.56 0.64
MACD 0.33 0.17
Stochastic Oscillator 85.93 92.64

Price Performance

Historical Comparison
CSTL
SNCY

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.

About SNCY Sun Country Airlines Holdings Inc.

Sun Country Airlines Holdings Inc operates low-cost air carriers. The business has two operating segments: Passenger and Cargo. The passenger segment has two internal passenger groups Scheduled service and Charter. The Cargo segment provides air cargo services. The majority of the revenue is from the passenger segment.

Share on Social Networks: